Friday, May 26, 2017
 
 
Company News: Page (1) of 1 - 05/18/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Statement from the Ministers of Health and Public Safety on Royal Assent of Bill C-37
 
(May 18, 2017)

OTTAWA, May 18 2017 /CNW/ - Today marks a momentous step forward for Canadians in addressing the devastating impacts of the overdose crisis on their loved ones and communities across Canada. With the Royal Assent of Bill C-37, which amended the Controlled Drugs and Substances Act and other acts, we now have additional tools and more flexibility to confront the factors underlying this crisis, while assisting those people on the front line in saving lives.

The Government of Canada is committed to an approach to this crisis that is comprehensive, collaborative, compassionate and evidence-based. We are pursuing a public health approach that also better equips law enforcement officials to reduce the harms associated with problematic substance use, including illegally-manufactured opioids.

With the passage of Bill C-37, we have streamlined the application process for communities that want and need supervised consumption sites. This new process fundamentally recognizes that, when properly established and maintained, supervised consumption sites save people's lives.


The new, simplified application form and process reduce the information burden on applicants, bringing it directly in line with the five key requirements spelled out by the Supreme Court of Canada. The process will be quicker and less cumbersome and will allow applicants to better respond to emerging health issues, while still protecting community health and safety.

Bill C-37 also includes measures to increase enforcement activities at the border to keep illicit substances, such as illegal opioids, out of Canada. This vital legislation strengthens our ability to stop the importation of unregistered devices used in the manufacturing of counterfeit opioids. It also gives officers at the border greater ability to protect the safety of Canadians by allowing them, under reasonable grounds, to open international mail weighing 30 grams or less. A 30 gram package could contain enough fentanyl to make as many as 15,000 fatal doses.

These are just two examples of the types of important measures that are now in place to help address this crisis. For more information, please visit Canada.ca/Opioids.

No one action, and no single piece of legislation, will solve this crisis before us. However, the passage of this bill is a significant step that, together with the efforts of many others, will help us to turn the tide.

 

SOURCE Health Canada

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Surgery, Medication, Judicial, Other,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market
  • Medical Imaging Equipment Market Is Expected To Reach USD 44,887.4 Mn By 2022, Credence Research
  • Growth Opportunities in the Global Diagnostic Imaging Market, 2017-2022 - Research and Markets

    Cancer
  • Artificial Intelligence Firm Set to Revolutionize Healthcare
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines